What if we could change the immune system's mind about what it's learned to attack?

That is the question I work on, in autoimmunity and transplant tolerance.

Joe Reda

Postdoctoral Researcher, NYU

Efferocytosis, the quiet clearing of dying cells, is how the body keeps the peace. I think it can be engineered to restore that peace where it has been lost.

Research Focus

Efferocytosis & Tolerance Transplant Tolerance Computational Immunology Protein Engineering In Vivo Immunology

Recent

2026

Leading Aim 2 of a Colton Center for Autoimmunity grant

Single-cell multiome analysis of human rheumatoid-arthritis samples

2026
Preprint posted on bioRxiv

Albumin-fused IL-10 prevents experimental autoimmune encephalomyelitis by promoting immunoregulation in the secondary lymphoid organs

2026
Paper published in Nature Biomedical Engineering

LDL-binding IL-10 reduces vascular inflammation in atherosclerotic mice

2025
Paper published in Science Translational Medicine

Liver-targeted allergen immunotherapy for allergic airway disease

Background

I design proteins that induce antigen-specific immune tolerance by engaging the pathways cells use to clear their dead. The work is aimed at autoimmune disease and, lately, at transplant tolerance, and it draws on protein engineering, immunology, and a fair amount of computation.

I also build my own computational tools to work more efficiently and ergonomically.

I did my Ph.D. at the University of Chicago's Pritzker School of Molecular Engineering, in Jeffrey Hubbell's lab, where this line of work began.

Learn more about my work

Expertise

Wet Lab

Protein engineering, spectral flow cytometry, mouse models of autoimmune disease, transplant tolerance, and allergic inflammation

Computational

High-dimensional spectral flow analysis in R and Python, single-cell multiome and spatial transcriptomics, and the small tools I write to keep it all reproducible